Heather J. Dalton, MD

Department

Obstetrics & Gynecology (Phoenix)

Position

Assistant Professor

Publications

• Gynecologic oncology
  Randall Leslie M., O'Malley David M., Adams Sarah, Duska Linda R., Dalton Heather, Huang Marilyn, Gaillard Stephanie, Monk Bradley J., Coleman Robert L., Holloway Robert W., , Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032)
  178, p. 161 - 169 2023
• Journal of clinical oncology
  Randall Leslie M., Monk Bradley J., O'Malley David M., ElNaggar Adam, O'Cearbhaill Roisin Eilish, Waggoner Steven E., Wang Zebin, Zhi Eric, Samnotra Vivek, Konstantinopoulos Panagiotis A., Cappuccini Fabio, Coleman Robert L., Gaillard Stephanie, Dalton Heather, Holloway Robert W., Huang Marilyn, Chon Hye Sook, Cloven Noelle Gillette, Adams Sarah F., Duska Linda R., MOONSTONE/GOG-3032: Interim analysis of a phase 2 study of niraparib + dostarlimab in patients (pts) with platinum-resistant ovarian cancer (PROC)
  40:16_suppl, p. 5573 - 5573 2022
• Clinical cancer research
  Roh Ju-Won, Yang XiaoYun, Huang Jie, Hu Wei, Jennings Nicholas B., Sehgal Vasudha, Sohn Bo Hwa, Han Hee Dong, Lee Sun Joo, Thanapprapasr Duangmani, Dalton Heather J., , Editor's Note: Biologic Effects of Platelet-Derived Growth Factor Receptor a Blockade in Uterine Cancer
  27:15, p. 4449 - 4449 2021
• Nature communications
  Rupaimoole Rajesha, Wu Sherry Y., Pradeep Sunila, McGuire Michael, Ivan Cristina, Pecot Chad V., Gharpure Kshipra M., Nagaraja Archana S., Armaiz-Pena Guillermo N., Zand Behrouz, Dalton Heather J., , Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression (Nature Communications, (2014), 5, 1, (5202), 10.1038/ncomms6202)
  11:1 2020
• Journal of clinical oncology
  Gourley Charlie, Buscema Joseph, Dalton Heather J., Banerjee Susana N., Krell Jonathan, Monk Bradley J., Lockley Michelle, PRO-105, a phase II open-label study of NUC-1031 in patients with platinum-resistant ovarian cancer
  36:15_suppl, p. TPS5612 - TPS5612 2018
• Gynecologic oncology
  Dalton Heather J, Sun Charlotte C, Bhosale Priya, Schmeler Kathleen M, Fleming Nicole D, Gershenson David M, Activity of bevacizumab-containing regimens in recurrent low-grade serous ovarian or peritoneal cancer: A single institution experience
  145:1, p. 37 - 40 2017
• Cancer
  Dalton H. J., Farley John H., Racial Disparities in Cervical Cancer: Worse than we Thought
  123:6, p. 915 - 916 2017
• Molecular cancer therapeutics
  Previs Rebecca A., Coleman Robert L., Sood Anil K., Dalton Heather J., Hansen Jean M., Merritt William M., Nick Alpa M., Langley Robert R., Armaiz-Pena Guillermo N., Pradeep Sunila, Lin Yvonne G., Davis Ashley N., Dual metronomic chemotherapy with nab-paclitaxel and topotecan has potent anti-angiogenic activity in ovarian cancer
  14:12, p. 2677 - 2686 2015
• Journal of minimally invasive gynecology
  Gómez-Hidalgo Natalia Rodriguez, Jhingran Anuja, Darin Maria Cecilia, Dalton Heather, Fleming Nicole, Brown Jubilee, Ramirez Pedro T., Ovarian Torsion After Laparoscopic Ovarian Transposition in Patients With Gynecologic Cancer: A Report of Two Cases
  22:4, p. 687 - 690 2015
• Gynecologic oncology research and practice
  Dalton Heather J, Rocconi Rodney P, Recio Fernando O, Monk Bradley J, McClure Candace K, Levocchio John L, Burrell Matthew O, Fiorica James, In vitro chemoresponse in metachronous pairs of gyneclologic cancers
  1:1, p. 7 - 7 2014
• Anticancer Research
  Dalton H. J., Fiorica J. V., Wang T., Benjamin I., Rocconi R. P., Recio F. O., Lovecchio J. L., Burrell M. O., Shahin M. S., Grendys E. C., Monk Bradley J., Edwards R. P., In vitro chemoresponse in metachronous pairs of ovarian cancers
  34:12, p. 7191 - 7196 2014
• Gynecologic oncology research and practice
  Foss Cassandra D, Farley John H, Monk Bradley J, Chase Dana M, Dalton Heather J, Protein profiling of ovarian cancers by immunohistochemistry to identify potential target pathways
  1:1, p. 4 - 4 2014
• Cancer research (Chicago, Ill.)
  Hu Wei, Mangala Lingegowda S, Liu Tao, Ivan Cristina, Sun Yunjie, Huang Jie, Rupaimoole Rajesh, Miyake Takahito, Dalton Heather J, Pradeep Sunila, , Notch3 pathway alterations in ovarian cancer
  74:12, p. 3282 - 3293 2014
• Clinical cancer research
  Tucker Susan L, Baggerly Keith A, Rupaimoole Rajesha, Lopez-Berestein Gabriel, Ozpolat Bulent, Gharpure Kshipra, Herbrich Shelley M, Unruh Anna K, Ivan Cristina, Hu Wei, Wu Sherry Y, Nick Alpa M, Crane Erin K, Coleman Robert L, Guenthoer Jamie, Dalton Heather J, Sood Anil K, Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancer
  20:12, p. 3280 - 3288 2014
• Clinical cancer research
  Roh Ju-Won, Dalton Heather J., Jennings Nicholas B., Sehgal Vasudha, HwaSohn Bo, Han Hee Dong, Lee Sun Joo, Thanapprapasr Duangmani, Hu Wei, Huang Jie, Yang XiaoYun, , Biologic Effects of Platelet-Derived Growth Factor Receptor alpha Blockade in Uterine Cancer
  20:10, p. 2740 - 2750 2014
• Cancer research (Chicago, Ill.)
  Dalton Heather J., Sood Anil K., Bar-Eli Menashe, Armaiz-Pena Guillermo N., Gonzalez-Villasana Vianey, Lopez-Berestein Gabriel, Monocyte Subpopulations in Angiogenesis
  74:5, p. 1287 - 1293 2014
• Clinical cancer research
  Liu Tao, Hu Wei, Dalton Heather J., Miyake Takahito, Song Jian H., Choi Hyun Jin, Huang Jie, Kang Yu, Pradeep Sunila, Wen Yunfei, , Targeting Src and Tubulin in Mucinous Ovarian Carcinoma
  19:23, p. 6532 - 6543 2013
• JNCI : Journal of the National Cancer Institute
  Kang Yu, Huang Jie, Wen Yunfei, Huang Jianfei, Liu Jinsong, Sood Anil K., Hu Wei, Ivan Cristina, Dalton Heather J., Miyake Takahito, Pecot Chad V., Zand Behrouz, Liu Tao, Lu Chunhua, Jennings Nicholas B., Rupaimoole Rajesha, Taylor Morgan, Pradeep Sunila, Wu Sherry Y., Role of Focal Adhesion Kinase in Regulating YB-1-Mediated Paclitaxel Resistance in Ovarian Cancer
  105:19, p. 1485 - 1495 2013
• Gynecologic oncology
  Zand B., Sood A., Bottsford-Miller J., Hu W., Nick A., Ivan C., Dalton H., Pecot C., Rupaimoole R., Separating the good, the bad, and the ugly: New directions in genomic prediction of outcome in ovarian cancer
  130:1, p. e5 - e6 2013
• Gynecologic oncology
  Zand B., Dalton H., Ivan C., Pecot C., Rupaimoole R., Bottsford-Miller J., Hu W., Nick A., Sood A., Deception of suppression: Unexpected effects of tristetraprolin in ovarian cancer
  130:1, p. e128 - e128 2013
• Cancer research (Chicago, Ill.)
  Miyake Takahito M., Pradeep Sunila, Zand Behrouz, Wiktorowicz John E., Dalton Heather J., Wen Yunfei, Kauffman Michael, McCauley Dilara, Shacham Sharon, Armaitz Pena Guillermo N., Sood Anil K., Abstract 5541: Therapeutic targeting of CRM1 in ovarian cancer
  73:8_Supplement, p. 5541 - 5541 2013
• Critical Reviews in Oncology/Hematology
  Monk Bradley J., Dalton Heather, Farley John H., Chase Dana M., Benjamin Ivor, Antiangiogenic agents as a maintenance strategy for advanced epithelial ovarian cancer
  86:2, p. 161 - 175 2013
• Gynecologic oncology
  Ivan Cristina, Hu Wei, Bottsford-Miller Justin, Zand Behrouz, Dalton Heather J., Liu Tao, Sood Anil K., Huang Jie, Nick Alpa M., Lopez-Berestein Gabriel, Coleman Robert L., Baggerly Keith A., Comprehensive epigenetic analysis of Notch pathway in high-grade serous ovarian cancer
  128:3, p. 506 - 511 2012
• Current Pharmaceutical Design
  Monk Bradley J., Dalton H., Benjamin I., Tanovic A., Trabectedin as a New Chemotherapy Option in the Treatment of Relapsed Platinum Sensitive Ovarian Cancer
  18:25, p. 3754 - 3796 2012
• Gynecologic Oncology
  Dalton H. J., Chan J. K., Hu L., Kapp D. S., Benjamin I., Monk Bradley J., Yu X., An economic analysis of dose dense weekly paclitaxel plus carboplatin versus every-3-week paclitaxel plus carboplatin in the treatment of advanced ovarian cancer
  124:2, p. 199 - 204 2012
• Gynecologic oncology
  Benjamin Ivor, Dalton Heather, Qiu Yue, Cayco Leslie, Johnson William G., Balducci James, Endometrial cancer surgery in Arizona: A statewide analysis of access to care
  121:1, p. 83 - 86 2011